DERCUM�S DISEASE Market SWOT Analysis, Future Growth, Forecast 2030

Amru20 Feb, 2023News

Emergence of cases of rare diseases can drive the market demand. Ultrasound therapy and other methods of non-invasive diagnosis are bound to bolster the market growth. This is backed by the large healthcare expenditure accorded by governments for the welfare of citizens. Research studies linking the disease to obesity disorders as well as patient genetic history can bode well for the market. Clinical trials are being conducted by pharmaceutical companies and government research institutes are touted to fuel the market due to development of new compounds or drugs. For instance, the novel compound RZL-012 without a generic or branded name has been known to target areas with lipomas and cause lipolysis. It has shown a moderate degree of success in a collaborated clinical trial conducted on women by Raziel Therapeutics and University of Arizona.